REFERENCES
1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.
3. Reddy YNV, Nishimura RA. Not all secondary mitral regurgitation is the same - potential phenotypes and implications for mitral repair. JAMA Cardiology 2020;5:1087-8.
4. Otto CM, Nishimura RA, Bonow RO, et al. Writing Committee Members. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;77:e25-197.
5. Petrus AHJ, Dekkers OM, Tops LF, Timmer E, Klautz RJM, Braun J. Impact of recurrent mitral regurgitation after mitral valve repair for functional mitral regurgitation: Long-term analysis of competing outcomes. Eur Heart J 2019;40:2206-14.
6. Enriquez-Sarano M, Sundt TM. Early surgery is recommended for mitral regurgitation. Circulation 2010;121:804-11.
7. Badhwar V, Peterson ED, Jacobs JP, et al. Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007. Ann Thorac Surg 2012;94:1870-7.
8. McNeely CA, Vassileva CM. Long-term outcomes of mitral valve repair versus replacement for degenerative disease: a systematic review. Curr Cardiol Rev 2015;11:157-62.
9. Vassileva CM, Mishkel G, McNeely C, et al. Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of medicare fee-for-service beneficiaries. Circulation 2013;127:1870-6.
10. Gammie JS, O’Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation 2007;115:881-7.
11. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381-7.
12. Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med 2016;374:344-53.
13. Hung J, Papakostas L, Tahta SA, et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation 2004;110:II85-90.
14. Suri RM, Clavel MA, Schaff HV, et al. Effect of Recurrent mitral regurgitation following degenerative mitral valve repair: long-term analysis of competing outcomes. J Am Coll Cardiol 2016;67:488-98.
15. Chikwe J, Toyoda N, Anyanwu AC, et al. Relation of mitral valve surgery volume to repair rate, durability, and survival. J Am Coll Cardiol 2017:S0735-1097(17)30677.
16. Bourguignon T, Bouquiaux-Stablo AL, Loardi C, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg 2014;148:2004-11.e1.
17. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 2009;119:1034-48.
18. Duncan BF, McCarthy PM, Kruse J, et al. Paravalvular regurgitation after conventional aortic and mitral valve replacement: a benchmark for alternative approaches. J Thorac Cardiovasc Surg 2015;150:860-8.e1.
19. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000;36:1152-8.
20. Safi AM, Kwan T, Afflu E, Kamme A Al, Salciccioli L. Paravalvular regurgitation: A rare complication following valve replacement surgery. Angiology 2000;51:479-87.
21. Genoni M, Franzen D, Vogt P, et al. Paravalvular leakage after mitral valve replacement: Improved long-term survival with aggressive surgery? Eur J Cardio-thoracic Surg 2000;17:14-9.
22. Onorati F, Perrotti A, Reichart D, et al. Surgical factors and complications affecting hospital outcome in redomitral surgery: insights from a multicentre experience. Eur J Cardio-thoracic Surg 2016;49:e127-33.
23. Vohra HA, Whistance RN, Roubelakis A, et al. Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience. Interact Cardiovasc Thorac Surg 2012;14:575-9.
24. Estévez-Loureiro R, Benito-González T, Garrote-Coloma C, et al. Percutaneous mitral repair: current and future devices. Ann Transl Med 2020;8:963.
25. Shah M, Jorde UP. Percutaneous mitral valve interventions (repair): current indications and future perspectives. Front Cardiovasc Med 2019;6:88.
26. Lim DS, Kunjummen BJ, Smalling R. Mitral valve repair with the mitraclip device after prior surgical mitral annuloplasty. Catheter Cardiovasc Interv 2010;76:455-9.
27. Pleger ST, Geis N, Kreusser M, et al. Percutaneous mitral valve repair in recurrent severe mitral valve regurgitation after mitral annuloplasty: MitraClip-in-the-ring as a complementary strategy. Herz 2019;46:54-60.
28. Niikura H, Bae R, Gössl M, Sun B, Mudy K, Sorajja P. Transcatheter Mitral valve repair of recurrent mitral regurgitation following mitral surgery. JACC Cardiovasc Interv 2019;12:1395-7.
29. Braun D, Frerker C, Körber MI, et al. Percutaneous edge-to-edge repair of recurrent severe mitral regurgitation after surgical mitral valve repair. J Am Coll Cardiol 2017;70:504-5.
30. Grasso C, Ohno Y, Attizzani GF, et al. Percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation in patients with surgical mitral valve repair failure. J Am Coll Cardiol 2014;63:836-8.
31. Estévez-Loureiro R, Arzamendi D, Carrasco-Chinchilla F, Amat-Santos IJ, Freixa X, Suárez de Lezo J. Usefulness of MitraClip for the treatment of mitral regurgitation secondary to failed surgical annuloplasty. Rev Esp Cardiol (Engl Ed) 2016;69:446-8.
32. Saji M, Rossi AM, Ailawadi G, Dent J, Ragosta M, Scott Lim D. Adjunctive intracardiac echocardiography imaging from the left ventricle to guide percutaneous mitral valve repair with the mitraclip in patients with failed prior surgical rings. Catheter Cardiovasc Interv 2016;87:E75-82.
33. Alkhouli M, Kawsara A, Alqahtani F, Badhwar V, Sengupta PP. Transcatheter mitral valve repair following ring annuloplasty: technical challenges and the role of invasive hemodynamics. JACC Cardiovasc Interv 2020;13:e207-9.
34. Kanda BS, Jay D, Farivar RS, Sorajja P. Leaflet-to-annuloplasty ring clipping for severe mitral regurgitation. JACC Cardiovasc Interv 2016;9:e63-4.
35. Hanson ID, Hanzel GS, Shannon FL. Mitral valve repair after annuloplasty ring dehiscence using MitraClip. Catheter Cardiovasc Interv 2016;88:301-6.
36. Avenatti E, El-Tallawi KC, Vukicevic M, Lawrie GM, Barker CM, Little SH. Percutaneous repair for recurrent mitral regurgitation after surgical repair: a mitraclip experience. Struct Hear 2018;2:147-54.
37. Walther T, Falk V, Dewey T, et al. Valve-in-a-valve concept for transcatheter minimally invasive repeat xenograft implantation. J Am Coll Cardiol 2007;50:56-60.
38. Eng MH, Wang DD. Transseptal transcatheter mitral valve replacement for post-surgical mitral failures. Interv Cardiol Rev 2018;13:77-80.
39. Whisenant B, Kapadia SR, Eleid MF, et al. One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve. JAMA Cardiol 2020;5:1245-52.
40. Cheung A, Webb JG, Barbanti M, et al. 5-Year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol 2013;61:1759-66.
41. Maisano F, Taramasso M. Mitral valve-in-valve, valve-in-ring, and valve-in-MAC: the Good, the Bad, and the Ugly. Eur Heart J 2019;40:452-5.
42. Simonato M, Whisenant B, Ribeiro HB, et al. Transcatheter mitral valve replacement after surgical repair or replacement: comprehensive mid-term evaluation of valve-in-valve and valve-in-ring implantation from the VIVID registry. Circulation 2021;143:104-16.
43. Yoon SH, Whisenant BK, Bleiziffer S, et al. Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings. J Am Coll Cardiol 2017;70:1121-31.
44. Paradis JM, Del Trigo M, Puri R, Rodés-Cabau J. Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical prosthetic dysfunction. J Am Coll Cardiol 2015;66:2019-37.
45. Yoon SH, Bleiziffer S, Latib A, et al. Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement. JACC Cardiovasc Interv 2019;12:182-93.
46. Bapat V, Pirone F, Kapetanakis S, Rajani R, Niederer S. Factors influencing left ventricular outflow tract obstruction following a mitral valve-in-valve or valve-in-ring procedure, part 1. Catheter Cardiovasc Interv 2015;86:747-60.
47. Babaliaros VC, Greenbaum AB, Khan JM, et al. Intentional percutaneous laceration of the anterior mitral leaflet to prevent outflow obstruction during transcatheter mitral valve replacement: first-in-human experience. JACC Cardiovasc Interv 2017;10:798-809.
48. Guerrero M, Wang DD, Himbert D, et al. Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification. Catheter Cardiovasc Interv 2017;90:1220-6.
49. Kamioka N, Babaliaros V, Morse MA, et al. Comparison of clinical and echocardiographic outcomes after surgical redo mitral valve replacement and transcatheter mitral valve-in-valve therapy. JACC Cardiovasc Interv 2018;11:1131-8.
50. Little SH, Bapat V, Blanke P, Guerrero M, Rajagopal V, Siegel R. Imaging guidance for transcatheter mitral valve intervention on prosthetic valves, rings, and annular calcification. JACC Cardiovasc Imaging 2020;14:22-40.
51. Blanke P, Dvir D, Cheung A, et al. A simplified D-shaped model of the mitral annulus to facilitate CT-based sizing before transcatheter mitral valve implantation. J Cardiovasc Comput Tomogr 2014;8:459-67.
52. Nez-Gil IJ, Gonalves A, Rodrguez E, et al. Transapical mitral valve-in-valve implantation: a novel approach guided by three-dimensional transoesophageal echocardiography. Eur J Echocardiogr 2011;12:335-7.
53. Rodés-Cabau J, Kalavrouziotis D. Transcatheter mitral valve-in-valve replacement: the new gold standard for treating mitral bioprosthesis failure? JACC Cardiovasc Interv 2018;11:1139-41.
54. García-Borbolla Fernández R, Sancho Jaldón M, Calle Pérez G, et al. Percutaneous treatment of mitral valve periprosthetic leakage. an alternative to high-risk surgery? Rev Esp Cardiol 2009;62:438-41.
55. Sorajja P, Cabalka AK, Hagler DJ, Rihal CS. Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients. Circ Cardiovasc Interv 2011;4:314-21.
56. Alkhouli M, Zack CJ, Sarraf M, et al. Successful percutaneous mitral paravalvular leak closure is associated with improved midterm survival. Circ Cardiovasc Interv 2017;10:e005730.
57. Cortés M, García E, García-Fernandez MA, Gomez JJ, Perez-David E, Fernández-Avilés F. Usefulness of transesophageal echocardiography in percutaneous transcatheter repairs of paravalvular mitral regurgitation. Am J Cardiol 2008;101:382-6.
